Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate)

Journal of Biomedical Materials Research - Part A

Volumn 77, Issue 1, 2006, Pages 103-111

  Kempen, Diederik H R ^a   Lu, Lichun ^a   Kim, Choll ^b   Zhu, Xun ^a   Dhert, Wouter J A ^c   Currier, Bradford L ^a   Yaszemski, Michael J ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Biodegradable microspheres; Bone tissue engineering; Composite scaffold; Drug delivery; Injectable material; Poly(propylene fumarate)

Indexed keywords

BIODEGRADATION; BIOMATERIALS; BONE; CELLS; COMPOSITE MATERIALS; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; MECHANICAL PROPERTIES; PROPYLENE; SCAFFOLDS; TRANSPLANTATION (SURGICAL);

BIODEGRADABLE MICROSPHERES; BONE TISSUE ENGINEERING; COMPOSITE SCAFFOLDS; DRUG DELIVERY; INJECTABLE MATERIAL; POLY(PROPYLENE FUMARATE);

ORGANIC POLYMERS;

FUMARIC ACID; MICROSPHERE; POLY(PROPYLENE FUMARATE); POLYMER; POLYPROPYLENE; UNCLASSIFIED DRUG;

ARTICLE; BONE DEFECT; CELL ADHESION; CONFOCAL MICROSCOPY; CONTROLLED DRUG RELEASE; OSSIFICATION; TISSUE ENGINEERING;

BONE CEMENTS; BONE REGENERATION; BONE SUBSTITUTES; DELAYED-ACTION PREPARATIONS; DEXTRANS; DRUG DELIVERY SYSTEMS; FUMARATES; INJECTIONS; LACTIC ACID; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; POLYPROPYLENES; SURFACE PROPERTIES; TISSUE ENGINEERING; XANTHENES;

EID: 33645962852     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30336     Document Type: Article

References (32)

1. Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg 1995;3:1-8.
2. Coventry MB, Tapper EM. Pelvic instability: a consequence of removing iliac bone for grafting. J Bone Joint Surg 1972;54A:83-101.
3. Damien JD, Parsons JR. Bone graft and bone graft substitutes: A review of current technologies and applications. J Appl Biomater 1991;2:187-208.
4. Norman-Taylor FH, Villar RN. Bone allograft: a cause for concern? J Bone Joint Surg 1997;79B:178-180.
5. Buck BE, Malinin TI, Brown MD. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop 1989;240:129-136.
6. Masuda T, Yliheikkila PK, Felton DA, Cooper DA. Generalizations regarding the process ad phenomenon of osseointegration. Part I. In vivo studies. Int J Oral Maxillofac Implant 1993;13:17-29.
7. Temenoff JS, Mikos AG. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 2000;21:2405-2412.
8. Peter SJ, Lu L, Kim DJ, Mikos AG. Marrow stromal osteoblast function on a poly(propylene fumarate)/β-tricalcium phosphate biodegradable orthopedic composite. Biomaterials 2000;21:1207-1213.
9. Fisher JP, Vehof JWM, Dean D, van der Waerden JCM, Holland TA, Mikos AG, Jansen JA. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res 2002;59:547-556.
10. Peter SJ, Miller ST, Zhu G, Yasko AW, Mikos AG. In vivo degradation of a poly(propylene fumarate)/β-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res 1998;41:1-7.
11. Payne RG, McGonigle JS, Yaszemski MJ, Yasko AW, Mikos AG. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 3. Proliferation and differentiation of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 2002;23:4381-4387.
12. Payne RG, McGonigle JS, Yaszemski MJ, Yasko AW, Mikos AG. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 2. Viability of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 2002;23:4373-4380.
13. Payne RG, Yaszemski MJ, Yasko AW, Mikos AG. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials 2002;23:4359-4371.
14. Jo S, Engel PS, Mikos AG. Synthesis of polyethylene glycol)-tethered poly(propylene-co-fumarate) and its modification with GRGD peptide. Polymer 2001;41:7595-7604.
15. Vehof JWM, Fisher JP, Dean D, van der Waerden JCM, Spauwen PHM, Mikos AG, Jansen JA. Bone formation in transforming growth factor β1 coated porous poly(propylene fumarate) scaffolds. J Biomed Mater Res 2002;60:241-251.
16. Kempen DHR, Kim CW, Lu L, Dhert WJA, Currier BL, Yaszemski MJ. Controlled release from poly(lactic-co-glycolic acid) microspheres embedded in an injectable, biodegradable scaffold for bone tissue engineering. Mater Sci 2003;426-432:3151-3156.
17. Hedberg EL, Tang A, Crowther RS, Carney DH, Mikos AG. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. J Control Rel 2002;84:137-150.
18. Kempen DHR, Lu L, Zhu X, Kim CW, Jabbari E, Dhert WJA, Currier BL, Yaszemski MJ. Development of biodegradable poly(propylene fumarate)/poly(lactic- co-glycolic acid) blend microspheres. I. Preparation and characterization. J Biomed Mater Res 2004;70A:283-292.
19. Kempen DHR, Lu L, Zhu X, Kim CW, Jabbari E, Dhert WJA, Currier BL, Yaszemski MJ. Development of biodegradable poly(propylene fumarate)/poly(lactic- co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation. J Biomed Mater Res 2004;70A:293-302.
20. Peter SJ, Suggs LJ, Yaszemski MJ, Engel PS, Mikos AG. Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J Biomater Sci Polym Ed 1999;10:363-373.
21. Lu L, Stamatas GN, Mikos AG. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles. J Biomed Mater Res 2000;50:440-451.
22. Lewandrowski KU, Cattaneo MV, Gresser JD, Wise DL, White RL, Bonassar L, Trantolo DJ. Effect of a poly (propylene fumarate) foaming cement on the healing of bone defects. Tissue Eng 1999;5:305-316.
23. Goldstein AS, Zhu G, Morris GE, Meszlenyi RK, Mikos AG. Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng 1999;5:421-434.
24. Yoon JJ, Park TG. Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res 2001;55:401-408.
25. th Annual Meeting of the Society for Biomaterials, April 2002, Tampa, FL.
26. Nam YS, Yoon JJ, Park TG. A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. J Biomed Mater Res 2000;53:1-7.
27. Peter SJ, Nolley JA, Widmer MS, Merwin JE, Yaszemski MJ, Yasko AW, Engel PS, Mikos AG. In vitro degradation of a poly(propylene fumarate)/β- tricalcium phosphate composite orthopedic scaffold. Tissue Eng 1997;3:207-215.
28. Ruhe PQ, Hedberg EL, Padron NT, Spauwen PH, Jansen JA, Mikos AG. rhBMP-2 release from injectable poly(DL-lactic-coglycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg 2003;85A(suppl 3):75-81.
29. van de Belt H, Neut D, Schenk W, van Horn JR, van der Me HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. Acta Orthop Scand 2001;6:557-571.
30. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty: review of 10905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg 1997;79B:590-595.
31. Peter SJ, Kim P, Yasko AW, Yaszemski MJ, Mikos AG. Crosslinking characteristics of an injectable poly(propylene fumarate)/β-tricalcium phosphate paste and the mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res 1999;44:314-321.
32. Sato T, Iwata H, Takahashi M, Miura T. Heat tolerance of activity toward ectopic bone formation by rabbit bone matrix protein. Ann Chir Gynaecol Suppl 1993;207:37-40.